Current status of symptomatic medical therapy in Parkinson’s disease

Por Factor, Stewart A.
Publicado no Neurotherapeutics (2008)

Promise of Pharmacogenomics for Drug Discovery, Treatment and Prevention of Parkinson’s Disease. A Perspective

Por Payami, Haydeh, Factor, Stewart A.
Publicado em 2013

Editorial: Neurotherapeutics of Movement Disorders

Por Factor, Stewart A., Jankovic, Joseph
Publicado em 2013

Advanced therapies for movement disorders in neurotherapeutics

Por Delong, Mahlon R., Factor, Stewart A.
Publicado no Neurotherapeutics (2008)

Psychogenic movement disorders: frequency, clinical profile, and characteristics.

Por Factor, S A, Podskalny, G D, Molho, E S
Publicado em 1995

Secondary Blepharospasm Associated with Structural Lesions of the Brain

Por Khooshnoodi, M. A., Factor, S. A., Jinnah, H. A.
Publicado em 2013

Tardive Dyskinesia: Therapeutic Options for an Increasingly Common Disorder

Por Cloud, Leslie J., Zutshi, Deepti, Factor, Stewart A.
Publicado em 2013

Tardive Syndromes are Rarely Reversible after Discontinuing Dopamine Receptor Blocking Agents: Experience from a University-based Movement Disorder Clinic

Por Zutshi, Deepti, Cloud, Leslie J., Factor, Stewart A.
Publicado no Tremor Other Hyperkinet Mov (N Y) (2014)

Psychodynamic Psychotherapy for Functional (Psychogenic) Movement Disorders

Por Sharma, Vibhash D., Jones, Randi, Factor, Stewart A.
Publicado no J Mov Disord (2017)

Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy.

Por Factor, S A, Sanchez-Ramos, J R, Weiner, W J
Publicado em 1988

The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's disease.

Por Weiner, W J, Factor, S A, Sanchez-Ramos, J R
Publicado em 1989

Internal Consistency of the University of Michigan RBD Questionnaire

Por Bliwise, Donald L., Scullin, Michael K., Factor, Stewart A.
Publicado em 2014

Saccades in Progressive Supranuclear Palsy–Maladapted, Irregular, Curved, and Slow

Por Shaikh, Aasef G., Factor, Stewart A., Juncos, Jorge L.
Publicado no Mov Disord Clin Pract (2017)

Do children with optic pathway tumors have an increased frequency of other central nervous system tumors?

Por Korones, David N., Padowski, Jeannie, Factor, Brad A., Constine, Louis S.
Publicado em 2003

The anatomy of a human foot with missing toes and reduplication of the hallux.

Por Hootnick, D R, Packard, D S, Levinsohn, E M, Factor, D A
Publicado em 1991

Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa

Por Smith, Yoland, Wichmann, Thomas, Factor, Stewart A, DeLong, Mahlon R
Publicado em 2012

Efficacy of sinemet CR4 in subgroups of patients with Parkinson's disease.

Por Factor, S A, Sanchez-Ramos, J R, Weiner, W J, Ingenito, A M
Publicado em 1989

A Neurodegenerative Disease Sleep Questionnaire: Principal Components Analysis in Parkinson’s Disease

Por Scullin, Michael K., Harrison, Tyler L., Factor, Stewart A., Bliwise, Donald L.
Publicado em 2013

Choice between delayed food and immediate oxycodone in rats

Por Secci, Maria E., Factor, Julie A., Schindler, Charles W., Panlilio, Leigh V.
Publicado no Psychopharmacology (Berl) (2016)

Quality improvement in neurology: Parkinson disease update quality measurement set: Executive summary

Por Factor, Stewart A., Bennett, Amy, Hohler, Anna D., Wang, David, Miyasaki, Janis M.
Publicado no Neurology (2016)